Crescendo Biologics Limited’s Post

A hallmark of cancer refers to a defining characteristic that enables the growth and survival of cancer cells. These include traits like sustained proliferative signaling, evasion of growth suppressors, resistance to cell death, and the ability to metastasize. Understanding these hallmarks is crucial for developing targeted therapies, as they represent the biological mechanisms driving tumor development and progression. Each hallmark highlights specific vulnerabilities that can be exploited for therapeutic intervention, forming the foundation for modern cancer research and treatment strategies.

LUSTGARTEN-FUNDED RESEARCH: Scientists have developed a blood test that can accurately detect early-stage pancreatic cancer, according to results from a large study. The blood test, developed by Ajay Goel, PhD, of City of Hope Duarte Cancer Center in California and his colleagues, analyzes small bits of RNA released by tumors. Read more about this ground-breaking research Lustgarten supports in partnership with @AACR and @SAAswim: https://lfdn.org/4bzGK4D #ResearchIsFundamental #ProgressIsParamount @cityofhope

We are excited to see Negative Results being published on ScieNFT! Publishing Negative results such as this one could mitigate the reproducibility crisis in science.. Dr. Christophe Raynaud’s latest study attempted to boost SLFN11 expression using CRISPR demethylation in breast cancer cells. https://lnkd.in/dKdzHeGk Despite no significant increase, this negative result is crucial. Publishing such findings helps refine future research and advance science. We celebrate all results — positive or negative. Join us in promoting transparency and accelerating scientific progress! #ScienceMatters #NegativeResults #CancerResearch #ScieNFT

💖 💖 Read the latest research "#Dual Stimuli-Responsive Multifunctional Silicon Nanocarriers for Specifically Targeting Mitochondria in Human Cancer Cells" by Vy Anh Tran et al. Paper link: https://shorturl.at/dknGX

✨ Notable Papers Related to #microRNA Research ✨ “From Molecular Mechanisms to Therapeutics: Understanding microRNA-21 in Cancer” by Jiho Rhim et al. from the National Cancer Center, Republic of Korea 👉 Full paper: https://lnkd.in/ePX9Ui_8 #cellsmdpi #cellbiology

We're here with another episode of #ChatGJP! With the American Association for Cancer Research #AACR annual meeting coming up next week, we asked our CSO Dr. Gary Patti "What breakthroughs has metabolomics contributed to in the field of cancer research?" Visit booth 3349 in San Diego to learn more about how our #metabolomics, #proteomics, and #multiomics solutions can provide breakthroughs in your research!

I love this study, such an intriguing finding on the biology of cancer recurrence, and with key implications for the treatment of Glioblastoma. It also shows the power of combining single cell with spacial biology in order to reveal this important recurrence mechanism. Congratulation to the authors!

Franco Cavaleri unveils a fascinating discovery in their research journey. ✨ In their exploration of cellular interactions, specifically focusing on BDNF (Brain-Derived Neurotrophic Factor) for neurological activity, Franco shares an exciting development. Their curcuminoids, BioBDMC30™ and BIOBDMC50, initially studied for other purposes, are exhibiting promising results against certain cancer cell lines, particularly MCF-7 cells associated with breast cancer. This accidental finding sparks enthusiasm as they delve deeper into understanding the mechanism. The potential implications for cancer treatment add an unexpected dimension to their research, showcasing the dynamic nature of scientific exploration. Watch the full video on YouTube for an insider's look into these remarkable revelations. 📽️: https://lnkd.in/gjhXpWXz #ScientificBreakthroughs #CancerResearch #nunubioceuticals #patented #francocavaleri

Abstracts: AACR Special Conference in Cancer Research: Tumor-body Interactions: The Roles of Micro- and Macroenvironment in Cancer https://bit.ly/3CCCV2A #AACRtumorenviron24 #AACRTME

discussing the role of translational research programs in ovarian cancer: the Humanitas experience.#ovariancancer. #liquidbiopsy. #earlydiagnosis